Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy

被引:0
|
作者
Charkviani, Mariam
Vaughan, Lisa E.
Sandahl, Tyler B.
Lin, Yi
Leung, Nelson
Herrmann, Sandra M.
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7542
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Acute Kidney Injury after Chimeric Antigen Receptor T-Cell Therapy for Pediatric Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Fitzgerald, Julie
    Elgarten, Caitlin W.
    Getz, Kelly D.
    Li, Yimei
    Hogan, Jonathan
    Dinofia, Amanda
    Burrows, Evanette K.
    Aplenc, Richard
    Grupp, Stephan A.
    Laskin, Benjamin
    Maude, Shannon L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [42] Acute kidney injury following chimeric antigen receptor T-cell therapy: Epidemiology, mechanism and prognosis
    Yang, Yang
    Luo, Kaiping
    Xu, Gaosi
    CLINICAL IMMUNOLOGY, 2024, 266
  • [43] Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy
    Qiu, Lei
    Zhu, Feng
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Hu, Yongxian
    Huang, He
    REGENERATIVE THERAPY, 2020, 14 : 271 - 274
  • [44] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [45] Patterns of Cytokine Release Syndrome with Teclistamab in Relapsed/Refractory Multiple Myeloma with or without Prior T-Cell Redirection Therapy
    Hamadeh, S.
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross
    Wang, Alice
    Korde, Neha
    Hultcrantz, Malin
    Lesokhin, Alexander
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Maclachlan, Kylee H.
    Patel, Dhwani
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar Boutros
    Chung, David
    Landau, Heather
    Giralt, Sergio A.
    Usmani, Saad Z.
    Tan, Carlyn Rose
    BLOOD, 2023, 142
  • [46] Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Hamadeh, Issam
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross
    Wang, Alice
    Korde, Neha
    Hultcrantz, Malin
    Lesokhin, Alexander
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi
    Maclachlan, Kylee
    Patel, Dhwani
    Shah, Gunjan
    Scordo, Michael
    Lahoud, Oscar
    Chung, David
    Landau, Heather
    Giralt, Sergio
    Usmani, Saad
    Tan, Carlyn Rose
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S40 - S40
  • [47] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
    Yang, Jinrong
    Zhou, Weilin
    Li, Dan
    Niu, Ting
    Wang, Wei
    CANCER LETTERS, 2023, 553
  • [48] NURSING IMPLICATIONS FOR MULTIPLE MYELOMA PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [49] Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Lawal, Odunayo
    Lupak, Oleksandra
    Udo, Itoro
    Emole, Josephine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S454 - S454
  • [50] Nursing implications for multiple myeloma patients undergoing chimeric antigen receptor (CAR) T-cell therapy
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E350 - E350